Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Nanotechnology approaches to addressing HER2-positive breast cancer

Fig. 4

a Fluorescent microscope images of MDA-MB-453 and MDA-MB-231 human breast cancer cells after 1 h and 4 h of incubation with FITC-conjugated dendrimers (Dend–FITC) and TZ-conjugated Dend–FITC (TZ–Dend–FITC); b fluorescent microscope images of co-cultured MDA-MB-453 and MDA-MB-231 human breast cancer cells followed by incubation with TZ–Dend–FITC; c quantitative uptake of TZ–Dend–FITC by MDA-MB-453 and MDA-MB-231 human breast cancer cells after 2 h incubation with or without TZ (20 mM). Figure reproduced from Kulhari et al. (2016) with permission

Back to article page